2 days Lifecore Biomedical (LFCR) Reports Q2 Loss, Tops Revenue Estimates Zacks
Lifecore Biomedical (LFCR) delivered earnings and revenue surprises of 7.41% and 9.64%, respectively, for the quarter ended November 2024. Do the numbers hold clues to what lies ahead for the stock?
X